Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)

por Sewell, J M, Macleod, K G, Ritchie, A, Smyth, J F, Langdon, S P
Publicado 2002

Mauritian Endemic Medicinal Plant Extracts Induce G2/M Phase Cell Cycle Arrest and Growth Inhibition of Oesophageal Squamous Cell Carcinoma in Vitro

por Rummun, N., Hughes, R. E., Beesoo, R., Li, W. W., Aldulaimi, O., Macleod, K. G., Bahorun, T., Carragher, N. O., Kagansky, A., Neergheen-Bhujun, V. S.
Publicado 2019

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868

por Simpson, B J B, Bartlett, J M S, Macleod, K G, Rabiasz, G, Miller, E P, Rae, A L, Gordge, P, Leake, R E, Miller, W R, Smyth, J, Langdon, S P
Publicado 1999

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

por Bartlett, J. M., Langdon, S. P., Simpson, B. J., Stewart, M., Katsaros, D., Sismondi, P., Love, S., Scott, W. N., Williams, A. R., Lessells, A. M., Macleod, K. G., Smyth, J. F., Miller, W. R.
Publicado 1996